Actively Recruiting
Difference of Tear Ferning Between Pre-and Post-menopausal Women and Between Post-menopausal Women with or Without Hormone Replacement Therapy (HRT)
Led by Chung Shan Medical University · Updated on 2025-02-27
90
Participants Needed
1
Research Sites
4 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research investigates the differences in tear ferning patterns between women before and after menopause, including those using hormone replacement therapy (HRT). The study focuses on women with dry eye syndrome to better understand how menopause and HRT may affect tear structure and related eye health. The trial is interventional and sponsored by Chung Shan Medical University. Participants are divided into two groups: pre-menopausal women with dry eye syndrome and post-menopausal women with dry eye syndrome. The study collects clinical information along with tear and blood samples. Measurements include tear volume, tear osmolarity, intraocular pressure, and tear break-up time. Hormone levels related to menopause are assessed using an enzyme-linked immunosorbent assay (ELISA). During the study, participants undergo several tests, including Schirmer's test, tear film breakup time, ocular surface evaluation, and tear ferning analysis. Blood samples are collected for hormone analysis. The study also measures intraocular pressure and uses questionnaires to assess ocular surface disease symptoms. Participation involves multiple assessments lasting from minutes to hours, with no masking or randomization involved.
CONDITIONS
Brief Title
Difference of Tear Ferning Between Women with and Without Menopausal.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged between 20 and 65 years
You will not qualify if you...
- No evident ocular diseases such as cornea, cataracts, vitreous degeneration, glaucoma, and retinopathy
- Belong to vulnerable groups (pregnant women, prisoners, ethical minorities, economically or educationally disadvantaged subjects, disabled individuals such as those at terminal stage of tumorigenesis, blindness, terminally ill individuals)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single day assessment
Participants undergo measurements including tear ferning structure, tear volume, tear osmolarity, intraocular pressure, tear break-up time, and blood sampling for hormone analysis.
1 visit (in-person)
Duration - Up to 6 months
Participants are observed for differences in tear ferning and ocular surface status related to menopausal status and hormone replacement therapy.
Follow-up visits may occur as part of monitoring
Trial Site Locations
Total: 1 location
1
Jen-Ai Hospital
Taichung, Taiwan, Taiwan, 412
Actively Recruiting
Research Team
D
David P Lin, PhD
Y
Yiting Tian, Master
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here